XLVvsXLVIETF Comparison
VS
ETF 2
XLVI
State Street Health Care Select Sector SPDR Premium Income Fund
This fund is part of
Options Strategies
-0.15%
State Street Health Care Select Sector SPDR ETF (XLV) belongs to the US Health Care segment. State Street Health Care Select Sector SPDR Premium Income Fund (XLVI) is part of the Options Strategies segment. Both ETFs have the same top 3 sector exposures: Healthcare and Consumer Non-Cyclicals. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.35% for XLVI. XLV is up 5.91% year-to-date (YTD) with +$963M in YTD flows. XLVI performs better with 6.87% YTD performance, and +$8M in YTD flows. Run a side-by-side ETF comparison of XLV and XLVI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLV vs XLVI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLV XLVI | +6.02%+3.76% | +13.21%+10.89% | +5.91%+6.87% | +21.88%+20.59% | +25.71%n/a | +34.93%n/a |
| Flows | XLV XLVI | +$1.43B+$3M | -$177M+$5M | +$963M+$8M | +$2.15B+$19M | -$5.26B- | +$3.47B- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLV XLVI | +18.26%+12.22% | +15.69%+11.06% | +14.32%n/a | +14.97%n/a |
| Max drawdown | XLV XLVI | -3.83%-2.03% | -10.51%-8.21% | -17.05%n/a | -17.05%n/a |
| Max drawdown duration | XLV XLVI | 17d7d | 116d115d | 444dn/a | 444dn/a |
Trading data
XLV | XLVI | |
Last sale 7/24/2026 at 1:30 PM | $162.57 | $26.52 |
| Previous close 07/24/2026 | $161.44 | $26.33 |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XLVI
is actively managed and doesn’t replicate an indexXLV | XLVI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
XLV | XLVI | |
|---|---|---|
| Last price | $162.57 | $26.52 |
| 1D performance | +0.70% | +0.72% |
| AuM | $42.54 B | $19.35 M |
| E/R | 0.08% | 0.35% |
Characteristics
XLV | XLVI | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | State Street Investment Management | State Street Investment Management |
| Benchmark | S&P Health Care Select Sector Index | - |
| N° of holdings | 59 | 59 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 1998 | July 30, 2025 |
| ESG | No | No |
Advertisement
Exposure
Countries
XLV
USA
97.92%
Other
2.08%
XLVI
USA
100.53%
Other
-0.53%
Sectors
XLV
Healthcare
97.73%
Other
2.27%
XLVI
Healthcare
100.33%
Other
-0.33%
Diversification
XLV
Total weight of top 15 holdings out of 15
72.82%
XLVI
Total weight of top 15 holdings out of 15
74.76%
Top 15 holdings
Data as of June 30, 2026
XLV
Eli Lilly & Co.
16.57%
Johnson & Johnson
10.68%
AbbVie, Inc.
7.76%
UnitedHealth Group, Inc.
6.59%
Merck & Co., Inc.
5.54%
Amgen, Inc.
3.41%
Thermo Fisher Scientific, Inc.
3.25%
Abbott Laboratories
2.76%
Gilead Sciences, Inc.
2.74%
Intuitive Surgical, Inc.
2.46%
Pfizer Inc.
2.40%
CVS Health Corp.
2.31%
Vertex Pharmaceuticals, Inc.
2.20%
Danaher Corp.
2.10%
Bristol Myers Squibb Co.
2.05%
XLVI
Eli Lilly & Co.
17.01%
Johnson & Johnson
10.96%
AbbVie, Inc.
7.97%
UnitedHealth Group, Inc.
6.77%
Merck & Co., Inc.
5.69%
Amgen, Inc.
3.50%
Thermo Fisher Scientific, Inc.
3.34%
Abbott Laboratories
2.83%
Gilead Sciences, Inc.
2.81%
Intuitive Surgical, Inc.
2.53%
Pfizer Inc.
2.46%
CVS Health Corp.
2.37%
Vertex Pharmaceuticals, Inc.
2.26%
Danaher Corp.
2.15%
Bristol Myers Squibb Co.
2.11%
Frequently asked questions about XLV and XLVI
How have the XLV and XLVI ETFs performed in 2026?
As of July 24, 2026, XLV is up 5.91% year-to-date (YTD), while XLVI has returned 6.87%. That puts XLVI better performer ahead so far this year.
Which ETF is attracting more investor money: XLV or XLVI?
Year-to-date, the XLV ETF saw +$963M in flows, compared to +$8M for XLVI.
Which ETF is more volatile: XLV or XLVI?
Over the past year, XLV had a volatility of 15.69%, while XLVI experienced 11.06%.
Which ETF is bigger: XLV or XLVI?
As of July 24, 2026, XLV holds $42.54 B in assets under management (AUM), while XLVI manages $19.35 M.
What sectors do the XLV and XLVI ETFs invest in?
XLV leans toward sectors like Healthcare. Meanwhile, XLVI focuses on Healthcare.
What are the top holdings of the XLV ETF and XLVI ETF?
XLV top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. XLVI holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: XLV or XLVI?
XLV holds 59 securities with 72.82% of its assets in the top 15. XLVI has 59 securities and a top 15 weight of 74.76%.
Advertisement
Latest news about XLV & XLVI
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
